Teenager Megan Lancaster, 19, was finally diagnosed with uterus didelphys - a congenital condition featuring two uteruses, two cervixes and two vaginas - after years of doctors dismissing her heavy, painful periods and STD-like symptoms, a delay that led to a life-threatening bout of sepsis in February 2026.
The diagnosis came after an ultrasound performed at Leeds Beckett University revealed the rare anomaly, prompting emergency surgery to drain a blocked uterus that had filled with four years' worth of blood. Megan's case underscores how uncommon reproductive disorders can be overlooked, leaving young women vulnerable.
What Is Uterus Didelphys and How Common Is It?
Uterus didelphys, also known as a double uterus, is a rare congenital malformation that occurs when the two Müllerian ducts, which normally fuse to form a single uterus, fail to merge during fetal development. The condition results in two separate uterine cavities, each with its own cervix, and often a double vagina. Medical literature estimates the prevalence at roughly one in a million women, though exact numbers are uncertain because many cases remain undiagnosed without imaging.
How Megan's Symptoms Were Misinterpreted
From age 13, Megan experienced unusually heavy menstrual bleeding that left her bedridden for days. At 16, she began noticing symptoms she described as "STD-like," including abnormal discharge and pelvic discomfort. Despite multiple visits to a sexual health clinic and her general practitioner (GP), all tests for sexually transmitted infections returned negative, and clinicians repeatedly prescribed hormonal contraception without addressing the underlying cause.
"Whenever I was on my period, I wouldn't be able to get out of bed or anything because it was so heavy, so I'd miss a lot of my lectures," Megan recalled. "I've always had really bad periods, but every time I'd go to the doctor for it they just put me on the Pill. And my body didn't agree with it in most cases."
Her complaints were often met with statements such as "this is bad but we don't know what to do," reflecting a broader gap in research and training on rare gynecological conditions.
The Turning Point: Ultrasound Diagnosis
In her first year at Leeds Beckett University, a doctor, though not a specialist in gynecology, ordered an ultrasound to investigate Megan's persistent pain. The scan revealed two complete uterine structures, two cervices and a duplicated vaginal canal. The physician, uncertain of the terminology, simply told Megan, "you've got two of everything," and admitted she did not know the condition's name.
Following the scan, Megan was informed she had uterus didelphys in February 2026. She also learned she had OHVIRA syndrome, a related congenital anomaly involving obstructed vaginal or uterine structures, which can exacerbate menstrual blockage and infection risk.
Sepsis and Emergency Surgery
While awaiting a specialist gynecology appointment, Megan's condition deteriorated. She returned home to Lancaster feeling feverish and unwell, prompting a call to NHS 111. An out-of-hours GP advised immediate attendance at Accident & Emergency (A&E). Upon arrival, Megan began vomiting, passing out, and was swiftly admitted.
Doctors identified a blocked uterus that had accumulated blood over four years, creating an environment for bacterial overgrowth. The infection progressed to sepsis, a systemic, potentially fatal response. Megan required urgent surgery to open the obstructed uterine cavity and drain the accumulated blood. A laparoscopic approach was attempted but failed because the inflamed uterus could not accommodate the camera, necessitating an open procedure.
Two months later, a second operation was performed to reopen the left uterus after postoperative healing threatened another blockage.
Current Health Status and Ongoing Challenges
Post-surgery, Megan reports that her periods remain as heavy as before, effectively experiencing two simultaneous menstrual cycles each month. Pain management is limited to over-the-counter paracetamol, and she has had only one follow-up appointment with a gynecologist, who also expressed limited knowledge about her condition.
"Even then they didn't really know anything either, they haven't particularly kept me in the loop," she said. "I just feel overwhelmed by it. They just never cared really, until it became serious."
What Is Known About Managing Uterus Didelphys?
Management of uterus didelphys depends on symptom severity and reproductive goals. Common approaches include:
- Regular monitoring with ultrasound to assess uterine shape and potential obstruction.
- Surgical correction, such as metroplasty, to unify the uterine cavities in women desiring pregnancy.
- Hormonal therapy to regulate menstrual flow, though effectiveness varies.
- Pain management strategies, ranging from NSAIDs to specialist pain clinics.
Pregnancy in women with uterus didelphys carries higher risks of miscarriage, preterm labor, and breech presentation, but many achieve successful deliveries, especially with specialist obstetric care.
Broader Implications for Women's Health Care
Megan's experience highlights several systemic issues:
- Limited awareness among primary-care providers about rare Müllerian anomalies.
- Reliance on symptom-based treatment without thorough imaging when standard therapies fail.
- Insufficient referral pathways to specialist gynecology services.
- Potential for serious complications, such as sepsis, when obstructive anomalies go undetected.
Improving education on congenital reproductive disorders in medical curricula and establishing clear guidelines for when to order pelvic imaging could reduce delays in diagnosis.
What Comes Next for Megan?
While Megan continues to manage heavy periods and occasional pain, she is awaiting a comprehensive gynecological review to discuss long-term treatment options, including possible surgical unification of her uterine cavities. She also plans to use her platform as a filmmaking student to raise awareness about uterus didelphys and encourage other women to seek thorough investigations when symptoms persist.
Healthcare providers are urged to consider structural anomalies in patients with refractory menstrual symptoms, especially when standard treatments fail to provide relief.